NEW YORK–(BUSINESS WIRE)–Henry’s Original (Henry’s), a private California-based vertically-integrated cannabis company and brand, announced it closed a Series B investment led by Merida Capital Partners (Merida), a private equity firm focused solely on the cannabis and hemp industries. Henry’s intends to use the funds to expand its cultivation, processing, sales and marketing operations. This investment round also included investments from Big Rock Partners, Delta Emerald Ventures and funds managed by JW Asset Management. The majority of Series A investors also invested in this round as well.
Congrats to @HenrysOriginal closing a $11 million Series B investment led by @MeridaCap to expand its cultivation, processing, sales and marketing operations in California. #cannabis #investing #investors
Henry’s produces Clean Green-certified flower and pre-roll products that are cultivated entirely in Mendocino County, California. The company holds thirteen state licenses which includes nursery, cultivation, processing, distribution and a retail dispensary license. The company has more than 100,000 square feet of cultivation in California.
“As a company that represents the legacy of Mendocino County family-farmers and original rebels in the cannabis revolution, we are excited to partner with some of the most strategic, thoughtful visionaries in the space,” said Henry’s Chief Executive Officer Jamie Warm. “Merida’s diverse team of experts understand and are extremely supportive of our vision to scale our hand-crafted consumer packaged goods with a regional identity in California as well as new markets around the country.”
“As one of the leading pre-roll and pre-packaged flower companies in California in overall sales, this investment positions us to scale our operations, continue to shore up the supply chain and drive growth,” said Henry’s President and COO Joshua Keats.
“Henry’s is well-positioned to gain significant market share in California, the biggest market in the country and the world, and Merida sees the potential to elevate the company as it crosses the fragmentation gap geographically in and outside of the Golden State,” said Mina Mishrikey, partner at Merida. “With a powerful legacy, brand identity and farm-direct, sungrown, Clean Green Certified products, Henry’s is a perfect fit for our portfolio. We look forward to adding value to the company as it expands its operations and working closely with Jamie, Josh, and their team.”
Henry’s high-quality genetics are tested to ensure its products, which include flower, pre-rolls, singles and a flower vape pen, meet and surpass California State standards, which are some of the strictest agricultural standards in the world. Currently, Henry’s products are available in more than 250 dispensaries across California, including at The Apothecarium, Harborside, Harvest SF, MedMen, Blum and many others.
Henry’s Original (Henry’s) is a private California-based vertically-integrated cannabis company and brand, whose popular flower and pre-roll products are cultivated entirely in Mendocino County. Henry’ high-quality genetics are tested to ensure its products, which include flower, pre-rolls, singles, and flower vape cartridges in 15 different seasonal varieties of thc and CBD-heavy variants, which meet and surpass California State standards. These standards are some of the strictest agricultural standards in the world. Currently, Henry’s products are available in more than 250 dispensaries across California, including at The Apothecarium, Harborside, Harvest SF, MedMen, Erba, and others. For more information, visit https://henrysoriginal.comor follow us on Instagram @henrysoriginal, @roccosroadtrip and @henrysoghouse.
Merida Capital Partners is a private equity firm targeting fundamental growth drivers which accelerate the rapid development of the cannabis and hemp industries. Merida’s motto, Responsible Investing across the Cannabis Ecosystem, highlights its focus on cultivation technologies, products and services associated with the evolution of cannabis and hemp as agricultural products, plant-based medicines, constituents in pharmaceutical formulations and recreational consumer products. For more information, visit www.meridacap.com or follow us on Twitter @meridacap.
Founder & Interim Editor of L.A. Cannabis News